Header Logo

Connection

CHRIS AMOS to Receptors, Adrenergic, beta-1

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Receptors, Adrenergic, beta-1.
CHRIS AMOS
Connection Strength
0.188
Receptors, Adrenergic, beta-1
  1. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. PLoS Med. 2022 02; 19(2):e1003897.
    View in: PubMed
    Score: 0.188
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.